Aqemia raises €1 million pre-seed round to disrupt drug discovery market
Summary
Aqemia, a Parisian deep tech startup, has raised €1 million pre-seed round from Elaia to develop its molecule matching technology. Aqemia’s core software, developed from academic research at École normale supérieure (PSL), can predict the effectiveness of a pharmaceutical drug. Speedy prediction is key, since identifying the best drug candidates for a given target requires sifting through millions of compounds. “This is in strong adequation with Elaia’s strategy for the PSL Innovation Fund to invest in early-stage companies with disruptive technologies. Specifically Levesque and COO Emmanuelle Martiano want to hire in silico drug hunters, software developer, and experts in generative artificial intelligence.
Funding
Amount
$1.8M
Total raised
Date
October 17, 2019
Announcement date
Investors
Elaia
Lead investors
Company
http://www.aqemia.com/
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected